Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Short Interest Down 81.5% in July

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) was the target of a large drop in short interest in July. As of July 15th, there was short interest totaling 3,905 shares, a drop of 81.5% from the June 30th total of 21,160 shares. Based on an average trading volume of 46 shares, the short-interest ratio is currently 84.9 days.

Towa Pharmaceutical Stock Performance

Towa Pharmaceutical stock opened at $26.00 on Monday. Towa Pharmaceutical has a 12-month low of $25.71 and a 12-month high of $26.00. The business’s 50-day moving average price is $25.53 and its two-hundred day moving average price is $25.40.

Wall Street Analyst Weigh In

Separately, Morgan Stanley upgraded shares of Towa Pharmaceutical to an “overweight” rating in a research report on Friday, June 12th. One analyst has rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of “Buy”.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.